gms | German Medical Science

57th Annual Meeting of the German Society of Neurosurgery
Joint Meeting with the Japanese Neurosurgical Society

German Society of Neurosurgery (DGNC)

11 - 14 May, Essen

Poster
P 05 Neurobiologie 1

Meeting Abstract (P 05.58)

Metronomic chemotherapy with temozolomide (TMZ) inhibits tumor growth and tumor angiogenesis in experimental glioma

Korn T, Erber R, Powajbo V, Tüttenberg J, Vajkoczy P
[Full Text]
Meeting Abstract (P 05.59)

NCAM-140 is down-regulated in human gliomas with increasing WHO grade – final results

Kuhn SA, Ebmeier K, Reichart R, Brodhun M, Ewald C, Dünisch P, Koblitz J, Kalff R
[Full Text]
Meeting Abstract (P 05.60)

Hypoxia-inducible carbonic anhydrase IX enhances invasion of glioma cells in vitro

Proescholdt MA, Mayer C, Huber S, Störr EM, Stanbridge E, Brawanski A
[Full Text]
Meeting Abstract (P 05.61)

Expression of lymphangiogenesis-related factors in glioblastomas – a novel aspect in glioma angiogenesis

Grau S, Trillsch F, Thon N, Tonn JC, Nelson P, Goldbrunner R
[Full Text]
Meeting Abstract (P 05.62)

A1 adenosine receptor deficiency in the host brain promotes the growth of inoculated glioblastoma cells

Synowitz M, Glass R, Faerber K, Kronenberg G, Schnermann J, Kettenmann H
[Full Text]
Meeting Abstract (P 05.63)

Endothelial ephrinB2/EphB4 signaling controls permeability of glioma blood vessels

Erber R, Eichelsbacher U, Powajbo V, Korn T, Djonov V, Ullrich A, Vajkoczy P
[Full Text]
Meeting Abstract (P 05.64)

Immune escape of malignant glioma: Interference with dendritic cell mediated immunity

Rapp M, Beetz T, Özcan Z, De Vleeschouwer S, Steiger HJ, Wernet P, Sorg RV, Sabel M
[Full Text]
Meeting Abstract (P 05.65)

Wif-1 and Rab34 as markers for early events in malignant astrocytoma genesis

Köhler S, Bozinov O, Henzgen J, Bertalanffy H, Sure U
[Full Text]
Meeting Abstract (P 05.66)

Target-specific reactivation of apoptosis pathways in malignant glioma

Kögel D, Hetschko H, Horn S, Weissenberger J
[Full Text]
Meeting Abstract (P 05.67)

Angiogenin – its expression pattern and functional role in human gliomas

Lemke B, Huppertz A, Kashfi F, Ketabi N, Unterberg A, Herold-Mende C
[Full Text]
Meeting Abstract (P 05.68)

Tissue microarray and survival analysis of 113 patients with gliomas

Ahmadi R, Joos S, Bandara S, Reifenberger G, Unterberg A, Herold-Mende C
[Full Text]
Meeting Abstract (P 05.69)

The proteasome inhibitor Bortezomib sensitizes primary glioblastoma multiforme cells for TRAIL-induced apoptosis

Koschny R, Holland H, Krupp W, Haas TL, Sykora J, Ganten TG, Ahnert P, Walczak H, Meixensberger J
[Full Text]
Meeting Abstract (P 05.70)

Expression and function of cannabinoid receptors in human gliomas

Dörner L, Mentlein R, Sahan G, Mehdorn HM, Held-Feindt FJ
[Full Text]
Meeting Abstract (P 05.71)

Serum-free generation of dendritic cells for clinical application in malignant glioma patients

Beetz T, Rapp M, Özcan Z, De Vleeschouwer S, Steiger HJ, Wernet P, Sorg RV, Sabel M
[Full Text]
Meeting Abstract (P 05.72)

Inhibition of cerebral endothelial cell proliferation and motility by RAF-1 small inhibitory RNA

Goldbrunner R, Gasser E, Miebach S, Tonn JC, Wagner E, Culmsee C
[Full Text]
Meeting Abstract (P 05.73)

Mutational and immunohistochemical analysis of ezrin-, radixin-, moesin (ERM) proteins in epilepsy associated glioneuronal lesions

Majores M, Schick V, Engels G, Fassunke J, Elger CE, Schramm J, Blumcke I, Becker AJ
[Full Text]
Meeting Abstract (P 05.74)

Expression of glutathione S-transferase T1 (GSTT1) in human brain tumours

Bock HC, Diedrich A, König F, Ludwig HC, Herken R, Quondamatteo F
[Full Text]